BerandaGRAL • NASDAQ
add
Grail Inc
$103,67
Setelah Jam Perdagangan Normal:(0,00%)0,00
$103,67
Tutup: 2 Feb, 16.32.39 GMT-5 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$97,82
Rentang hari
$97,81 - $103,79
Rentang tahun
$20,44 - $118,84
Kapitalisasi pasar
4,04 M USD
Volume Rata-Rata
819,30 rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 36,19 jt | 26,32% |
Biaya operasional | 145,03 jt | -25,53% |
Penghasilan bersih | -88,98 jt | 29,21% |
Margin laba bersih | -245,83 | 43,96% |
Penghasilan per saham | -2,46 | 29,77% |
EBITDA | -86,31 jt | 40,18% |
Tarif pajak efektif | 25,05% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 540,13 jt | -36,72% |
Total aset | 2,60 M | -16,58% |
Total liabilitas | 361,07 jt | -31,91% |
Total ekuitas | 2,24 M | — |
Saham yang beredar | 38,98 jt | — |
Harga terhadap nilai buku | 1,58 | — |
Tingkat pengembalian aset | -11,81% | — |
Tingkat pengembalian modal | -13,40% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -88,98 jt | 29,21% |
Kas dari operasi | -63,24 jt | 39,53% |
Kas dari investasi | 66,67 jt | 6.966,43% |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | 3,09 jt | 102,93% |
Arus kas bebas | -19,27 jt | 60,50% |
Tentang
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
In June 2021 Galleri launched their liquid biopsy, or multi-cancer early detection test, which they called Galleri test. In 2023 EU regulators ordered Grail to be spun-out from Illumina which was completed on June 24, 2024. Wikipedia
Didirikan
2015
Kantor pusat
Situs
Karyawan
1.000
